Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, February 23, 2012
Technology Networks
 
Register |
Home Page>Events
  Events
February 2012
Scientific News
Genomic Sequencing in Clinical Trials
In this article, researchers from Northwestern University Feinberg review the current and future directions of clinical research with respect to genomic sequencing.
Foundation Medicine and Dana-Farber Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal Cancer
Findings highlight clinical application of next-generation sequencing to suggest targeted therapeutic options for patients.
Transformational Fruit Fly Genome Catalog Completed
Scientists now have a reference manual that should speed gene discoveries in everything from pest control to personalized medicine.
Animal Cell Therapies Announces Cell Inventory Value at $6 Million
The evaluation demonstrates the importance of this first step in the company's mission to improve and extend the lives of dogs through innovative stem cell products and services.
Diffusion Pharmaceuticals Begins Clinical Trial for Treatment of Primary Brain Cancer
Company announced clinical trial testing of its lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM.
Drug Halts Organ Damage in Inflammatory Genetic Disorder
NIH study shows benefits of long-term Kineret therapy in people with NOMID.
Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies
Data highlights novel immunomodulatory effects of entinostat in renal and prostate cancer models.
Hunting Could Hurt Genetic Diversity of Sandhill Cranes, UW Research Suggests
Research uses DNA fingerprinting to assess the genetic makeup of cranes.
Results From Phase I Clinical Trials Demonstrate Positive Safety Data of AVI BioPharma's RNA-Based Therapeutics
AVI BioPharma, Inc. have announced positive safety results from all six dose cohorts in the single ascending dose studies of AVI-6002 and AVI-6003, AVI's lead drug candidates being evaluated for the treatment of Ebola virus and Marburg virus, respectively.
Compugen Cancer Target Results Demonstrate Significant Potential for Cancer Immunotherapy
Findings support CGEN-15001T's potential as a powerful drug target for cancer immunotherapy.
Company Logo
30 Jan 2012 - 01 Feb 2012
Washington, DC, USA
Phacilitate’s North American Cell & Gene Therapy Forum 2012
Company Logo
01 Feb 2012 - 04 Feb 2012
Vilamora, Algarve, Portugal
HEALTHINF 2012 - International Conference on Health Informatics
Company Logo
04 Feb 2012 - 08 Feb 2012
San Diego, CA, USA
SLAS2012, the First Annual SLAS Conference and Exhibition
Company Logo
22 Feb 2012 - 23 Feb 2012
Bethesda, Maryland
2012 Biospecimen Research Network Symposium: Advancing Cancer Research Through Biospecimen Science
Company Logo
27 Feb 2012 - 28 Feb 2012
Las Vegas, Nevada, Red Rock Casino, Resort & Spa
Oncology Partnering & Deal-Making Conference
Company Logo
27 Feb 2012 - 28 Feb 2012
Red Rock Casino, Resort & Spa, 11011 W. Charleston, Las Vegas, NV 89135
3rd Cancer Targets and Therapeutics
Company Logo
29 Feb 2012 - 01 Mar 2012
Tokyo, Japan
Asia Tides 2012




Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net